Focus
RSV
LATEST
RSV Vaccines May Increase Risk of Rare Neurological Condition
CDC officials are investigating a potential link between two recently approved RSV vaccines and increased reports of Guillain-Barré syndrome in adults over 60.
|
CDC Officials Investigating Nervous System Disorder in New Vaccine Recipients
Federal officials made the revelation in a CDC meeting this week.
|
RSV Shown to Damage Nerve Cells and Trigger Inflammation
Study suggests the virus has the potential to infect beyond the respiratory tract.
|
Children Have Higher Hospitalizations From RSV Than Omicron or Influenza
A recent research paper found that hospitalization rates were over 80 percent for RSV and only 30 percent for omicron and the flu.
|
Few Seniors Taking RSV Vaccines; Most Adults Decline New COVID-19 Shots: CDC Studies
Studies provide updates on vaccination uptake.
|
RSV Vaccine Added to List of 2024 Childhood Immunizations, Mpox Recommended for At-Risk Young Adults
The CDC’s new vaccine schedule recommends that infants receive their first RSV vaccine before the age of 6 months in most cases.
|
CDC Director Believes US May Have Hit Peak of RSV
The head of the CDC said that officials believe RSV levels have peaked in the United States.
|
Respiratory Illnesses on the Rise Across the US, CDC Warns
The CDC said that cases of respiratory viruses are on the rise across the U.S.
|
COVID-19 Is Less Frequent and Severe in Infants Than Other Respiratory Viruses, Study Finds
A study found infants under 2 months of age were less likely to experience SARS-CoV-2 infection and less severe illness compared with other respiratory viruses.
|
CDC Issues Alert on Shortage of Key Children’s Medication
The CDC sent a health alert over a shortage of nirsevimab, used to treat RSV.
|
RSV Treatment for Infants in Limited Supply: CDC
The CDC has recommended prioritizing infants at the highest risk for severe RSV owing to the short supply of monoclonal antibody nirsevimab.
|
CDC Advisers Recommend Pfizer RSV Vaccine for Pregnant Women
The CDC’s advisory committee has recommended the RSV vaccine for women in the late stages of their pregnancies.
|
COVID-19, RSV, and Flu May Place ‘Significant Strain’ on Health System: CDC
The CDC noted that fall and winter are generally a time when viruses that cause respiratory disease tend to circulate more heavily.
|
RSV Vaccines May Increase Risk of Rare Neurological Condition
CDC officials are investigating a potential link between two recently approved RSV vaccines and increased reports of Guillain-Barré syndrome in adults over 60.
|
CDC Officials Investigating Nervous System Disorder in New Vaccine Recipients
Federal officials made the revelation in a CDC meeting this week.
|
RSV Shown to Damage Nerve Cells and Trigger Inflammation
Study suggests the virus has the potential to infect beyond the respiratory tract.
|
Children Have Higher Hospitalizations From RSV Than Omicron or Influenza
A recent research paper found that hospitalization rates were over 80 percent for RSV and only 30 percent for omicron and the flu.
|
Few Seniors Taking RSV Vaccines; Most Adults Decline New COVID-19 Shots: CDC Studies
Studies provide updates on vaccination uptake.
|
RSV Vaccine Added to List of 2024 Childhood Immunizations, Mpox Recommended for At-Risk Young Adults
The CDC’s new vaccine schedule recommends that infants receive their first RSV vaccine before the age of 6 months in most cases.
|
CDC Director Believes US May Have Hit Peak of RSV
The head of the CDC said that officials believe RSV levels have peaked in the United States.
|
Respiratory Illnesses on the Rise Across the US, CDC Warns
The CDC said that cases of respiratory viruses are on the rise across the U.S.
|
COVID-19 Is Less Frequent and Severe in Infants Than Other Respiratory Viruses, Study Finds
A study found infants under 2 months of age were less likely to experience SARS-CoV-2 infection and less severe illness compared with other respiratory viruses.
|
CDC Issues Alert on Shortage of Key Children’s Medication
The CDC sent a health alert over a shortage of nirsevimab, used to treat RSV.
|
RSV Treatment for Infants in Limited Supply: CDC
The CDC has recommended prioritizing infants at the highest risk for severe RSV owing to the short supply of monoclonal antibody nirsevimab.
|
CDC Advisers Recommend Pfizer RSV Vaccine for Pregnant Women
The CDC’s advisory committee has recommended the RSV vaccine for women in the late stages of their pregnancies.
|
COVID-19, RSV, and Flu May Place ‘Significant Strain’ on Health System: CDC
The CDC noted that fall and winter are generally a time when viruses that cause respiratory disease tend to circulate more heavily.
|